UroGen Reports Fourth Quarter and Full Year 2017 Financial Results
Go back to UroGen Reports Fourth Quarter and Full Year 2017 Financial Results| (NASDAQ: URGN) | Delayed: 42.94 -0.15 (0.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.09 | 52 Week High | $ | |||
| Open | $42.59 | 52 Week Low | $ | |||
| Day High | $43.46 | P/E | N/A | |||
| Day Low | $42.58 | EPS | $ | |||
| Volume | 77,539 | |||||
